Request Trial
patent-stemcells
Chepko Danil Vitalevich / Shutterstock.com
7 July 2014BiotechnologyJoachim Wachenfeld

Patenting stem cells: filing date is the key

In the inaugural issue of the LSIPR quarterly, Andy Sanderson analysed options of obtaining patent protection in the aftermath of the Brüstledecision of the Court of Justice of the European Union (CJEU) that further restricted options of applicants to obtain patent protection for human embryonic stem (hES) cell-related inventions.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
‘Doing more with less’: In-house counsel on budgets and strategy
22 October 2025   Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.
Biotechnology
An update on patenting in Ukraine, Russia and Eurasia
2 September 2025   Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.
Biotechnology
Synthego clears rival’s patents from CRISPR market at Fed Circ
12 June 2025   Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art.


Editor's picks

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
Europe
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
8 January 2026

Editor's picks

Europe
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
8 January 2026
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025
Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025

More features

Arnold & Porter loses another regulatory partner to growing rival
CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’
Edwards v Meril: Inside the UPC’s landmark medtech showdown
Bird & Bird targets Nordic life sciences growth with regulatory hire
Key EU and UK regulatory changes to watch for in 2026
UPC: A review of 2025 and what to expect in 2026
Mental health in IP: ‘We have a clear picture of the problem’
From Edwards to Insulet: Three key medical device cases of 2025